Mitochondrial Fatty Acid β-Oxidation and Resveratrol Effect in Fibroblasts from Patients with Autism Spectrum Disorder
暂无分享,去创建一个
A. Casabona | R. Frye | L. Delhey | R. Barone | R. Rizzo | F. Djouadi | J. Bastin | P. J. McCarty | M. Karim | Indrapal N. Singh | Amrit Ammanamanchi | Rose Shannon | Leanna M. Delhey
[1] C. van der Merwe,et al. Genetic contributions to autism spectrum disorder , 2021, Psychological Medicine.
[2] R. Palmer,et al. Prenatal air pollution influences neurodevelopment and behavior in autism spectrum disorder by modulating mitochondrial physiology , 2020, Molecular Psychiatry.
[3] K. Shimomura,et al. Single administration of resveratrol improves social behavior in adult mouse models of autism spectrum disorder , 2020, Bioscience, biotechnology, and biochemistry.
[4] S. Ferdinandusse,et al. Mitochondrial Fatty Acid Oxidation Disorders: Laboratory Diagnosis, Pathogenesis, and the Complicated Route to Treatment , 2020, Journal of lipid and atherosclerosis.
[5] R. Palmer,et al. Early life metal exposure dysregulates cellular bioenergetics in children with regressive autism spectrum disorder , 2020, Translational Psychiatry.
[6] R. Frye. Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments. , 2020, Seminars in pediatric neurology.
[7] Mary C. Conrad,et al. Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder , 2020, Biological Psychiatry.
[8] R. Frye,et al. Developmental regression and mitochondrial function in children with autism , 2020, Annals of clinical and translational neurology.
[9] Z. Warren,et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2016 , 2020, Morbidity and mortality weekly report. Surveillance summaries.
[10] M. Fichera,et al. Clinical correlates in children with autism spectrum disorder and CNVs: Systematic investigation in a clinical setting , 2020, International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience.
[11] M. Malaguarnera,et al. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects , 2020, Antioxidants.
[12] M. Canfield,et al. The association between newborn screening analytes and childhood autism in a Texas Medicaid population, 2010–2012 , 2019, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[13] S. Ferdinandusse,et al. Impact of newborn screening for very‐long‐chain acyl‐CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes , 2019, Journal of inherited metabolic disease.
[14] R. Frye,et al. Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder , 2019, International journal of molecular sciences.
[15] F. Djouadi,et al. Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies , 2019, Cells.
[16] A. Pulvirenti,et al. A Subset of Patients With Autism Spectrum Disorders Show a Distinctive Metabolic Profile by Dried Blood Spot Analyses , 2018, Front. Psychiatry.
[17] J. Hesse,et al. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD) , 2018, Journal of Inherited Metabolic Disease.
[18] C. Hedin-Pereira,et al. Resveratrol Prevents Cellular and Behavioral Sensory Alterations in the Animal Model of Autism Induced by Valproic Acid , 2018, Front. Synaptic Neurosci..
[19] A. Nadeem,et al. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T+ Itpr3tf/J Mice , 2018, NeuroMolecular Medicine.
[20] B. H. Lo,et al. Autism Spectrum Disorder , 2018, Journal of paediatrics and child health.
[21] P. Carmeliet,et al. A Fatty Acid Oxidation-Dependent Metabolic Shift Regulates Adult Neural Stem Cell Activity , 2017, Cell reports.
[22] S. J. James,et al. Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] R. Frye,et al. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial , 2016, Molecular Psychiatry.
[24] A. Nordenström,et al. Neuropsychological Development in Patients with Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Deficiency. , 2015, JIMD reports.
[25] R. Frye,et al. Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome , 2015, Microbial ecology in health and disease.
[26] J. Brunstein. Mitochondrial genetic disorders. , 2015, MLO: medical laboratory observer.
[27] Stepan Melnyk,et al. Increased Susceptibility to Ethylmercury-Induced Mitochondrial Dysfunction in a Subset of Autism Lymphoblastoid Cell Lines , 2015, Journal of toxicology.
[28] B. Andresen,et al. Neurodevelopmental profiles of children with very long chain acyl-CoA dehydrogenase deficiency diagnosed by newborn screening. , 2014, Molecular genetics and metabolism.
[29] G. Zanatta,et al. Resveratrol prevents social deficits in animal model of autism induced by valproic acid , 2014, Neuroscience Letters.
[30] A. Guastella,et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis , 2014, Molecular Psychiatry.
[31] F. Djouadi,et al. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts , 2014, Orphanet Journal of Rare Diseases.
[32] D. Rossignol,et al. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism , 2014, Front. Physiol..
[33] R. Frye,et al. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder , 2013, Translational Psychiatry.
[34] F. Djouadi,et al. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. , 2011, Human molecular genetics.
[35] D. Rossignol,et al. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis , 2011, Molecular Psychiatry.
[36] D. Macfabe,et al. Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders , 2010, Journal of neurochemistry.
[37] Keith Hyland,et al. Fever Plus Mitochondrial Disease Could Be Risk Factors for Autistic Regression , 2010, Journal of child neurology.
[38] R. Wanders,et al. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation , 2010, Journal of Inherited Metabolic Disease.
[39] R. Wanders,et al. Genetic basis for correction of very-long-chain acyl-coenzyme A dehydrogenase deficiency by bezafibrate in patient fibroblasts: toward a genotype-based therapy. , 2007, American journal of human genetics.
[40] P. Filipek,et al. Relative Carnitine Deficiency in Autism , 2004, Journal of autism and developmental disorders.
[41] Tonya Clark-Taylor,et al. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase. , 2004, Medical hypotheses.
[42] R. Naviaux,et al. The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. , 2002, Archives of otolaryngology--head & neck surgery.
[43] Johan Auwerx,et al. Protein acetylation in metabolism — metabolites and cofactors , 2016, Nature Reviews Endocrinology.
[44] G. Arbanas. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) , 2015 .
[45] J. Bastin. Regulation of mitochondrial fatty acid β-oxidation in human: what can we learn from inborn fatty acid β-oxidation deficiencies? , 2014, Biochimie.
[46] Robert W. Taylor,et al. Biochemical assays of respiratory chain complex activity. , 2007, Methods in cell biology.